New Stool Test for Detecting Colorectal Cancer Could Reduce Unnecessary Colonoscopies
|
By LabMedica International staff writers Posted on 13 Feb 2024 |
|
Globally, around 1.9 million people are diagnosed with colorectal cancer each year, resulting in approximately 935,000 deaths. Early detection is key, as colorectal cancer can be cured if found early. However, symptoms like weight loss or blood in the stool often emerge too late for effective intervention. Consequently, many countries have initiated population-based screening programs. These programs commonly utilize the fecal immunochemical test (FIT), which detects the blood protein hemoglobin in stool samples. Colorectal cancer screening programs have been effective in diagnosing the disease at earlier stages and reducing mortality rates. Despite the current test’s effectiveness, there is a need for improvement, particularly in detecting larger premalignant polyps before they become invasive. Early detection would allow for these polyps to be removed during a colonoscopy instead of requiring surgery.
Researchers at the Netherlands Cancer Institute (Amsterdam, the Netherlandsl) have been developing a new test, the multitargetFIT-test (mtFIT), which measures hemoglobin and two additional proteins. An earlier retrospective study showed promising results. Now, a much larger, prospective study that compared the mtFIT to the current FIT in over 13,000 participants of the Dutch national population-based screening program has found that the new test yielded more positive results than the current test. This increase in positive results led to more colonoscopies being performed.
With the new mtFIT test, doctors found abnormalities in 299 individuals, compared to 159 individuals with the current FIT test. Most notably, the mtFIT identified a higher number of individuals with high-risk precursors to colon cancer (216 versus 114). The potential number of colorectal cancer cases that could be prevented using this new test varies, depending on how the current FIT test is implemented in different countries. For participants, the new test is as user-friendly as the existing one. Integrating mtFIT into existing FIT-based screening programs should be easy, as both tests require similar screening logistics.
“The new test can detect cancer precursors more effectively,” said Gerrit Meijer, Principal Investigator at the Netherlands Cancer Institute. “Our results predict that the test can reduce the number of new cases of colorectal cancer and mortality resulting from it. The new test detects more larger polyps without a significant increase in 'false-positive' results and thus unnecessary colonoscopies.”
Related Links:
Netherlands Cancer Institute
Latest Molecular Diagnostics News
- New Urine Test Improves Accuracy for Early Detection of Bladder Cancer in Patients with Hematuria
- New Blood Test Enables Accurate Diagnosis of Dementia and Neurological Diseases
- Low-Cost CRISPR-Based Paper Strip Test to Improve Flu Diagnosis and Surveillance
- AI-Powered Blood Test Predicts Parkinson's Seven Years before Symptoms Appear
- Rapid Diagnostic Test for Brain Tumors to Reduce Need for Invasive Surgical Biopsy
- New Blood Test Identifies Children with Rare Heart Condition
- Novel Immune-Based Biomarker Helps Detect Ovarian Cancer Years before Diagnosis
- Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods
- Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection
- Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes
- First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening
- Proteomics Platform Identifies Proteins in Blood to Give Cancer Warning 7 Years before Diagnosis
- AI Technology-Based Blood Test Identifies Lung Cancer Earlier
- Ultra-Sensitive Blood Test Predicts Breast Cancer Recurrence Months or Even Years before Relapse
- Prenatal Testing Offers Window for Finding Mother’s Cancer Risk
- New Molecular Test Detects More Cervical Cancer Cases
Channels
Clinical Chemistry
view channel
First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
Metabolic disorders such as diabetes and osteoporosis are rapidly increasing globally, especially in developing countries. Diagnosing these conditions generally requires blood tests; however, in remote... Read more
New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more
.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
Hematology
view channel
New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched... Read more
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read moreImmunology
view channel
Portable Device Analyzes White Blood Cell Activity to Monitor Cancer Patients’ Health
Chemotherapy and similar treatments aimed at eliminating cancer cells often adversely affect patients' immune cells. Each year, this results in tens of thousands of cancer patients suffering from weakened... Read more
New Test Detects Return of Blood Cancer a Year Earlier
Multiple myeloma, also known as Kahler's disease, is a type of blood cancer originating in the bone marrow characterized by the uncontrolled proliferation of plasma cells, a specific type of white blood cell.... Read more
Universal Blood Test Could Predict Organ Transplant Outcomes with Unprecedented Accuracy
In a landmark study, an interdisciplinary research team from The Westmead Institute for Medical Research (WIMR, NSW, Australia) and the University of Sydney (NSW, Australia) has identified, for the first... Read more.jpg "Image: The AI tool predicts whether someone’s cancer will respond to immune checkpoint inhibitors (Photo courtesy of National Cancer Institute)")
Microbiology
view channel
Rapid UTI Test Cuts Detection Time from 3 days to 45 Minutes
Antimicrobial Resistance (AMR), also known as antibiotic resistance or superbugs, is a silent but growing pandemic where bacteria have become resistant to lifesaving antibiotics due to decades of overuse and misuse.... Read more
POC STI Test Shortens Time from ED Arrival to Test Results
In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more
Integrated Solution Ushers New Era of Automated Tuberculosis Testing
Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read morePathology
view channel.jpg "Image: Green boxes highlight plasma cells — an indicator of infection — in a sample of the tissue lining the uterus (Photo courtesy of Zou lab and Montine lab)")
Customizable AI Tool Helps Pathologists Identify Diseased Cells
Pathologists are tasked with examining body fluids or tissues to diagnose diseases, a process that involves distinguishing rare disease-indicating cells from thousands of normal cells under a microscope.... Read more
New Automated Diagnostic Techniques to Improve Diagnosis of Inflammatory Diseases
Necroptosis, a type of cell death, is a natural mechanism through which the body eliminates unwanted or dangerous cells. This process can malfunction in some individuals, leading to diseases characterized... Read more
Technology
view channel
Microneedle Patch Detects Skin Cancer Early
Wearable bioelectronics has emerged as a significant innovation in healthcare, especially in the field of biosensing, providing a new method to monitor individual health for both diagnostic and therapeutic purposes.... Read more
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
Industry
view channel
Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing
Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more_1.jpg "Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)")